(MedPage Today) — Tiny biodegradable needles made of silk protein may one day deliver ouchless injections, researchers suggested. Also in this week’s Lab Notes installment: stem cell wrapping to slow brain cancer.
No Comments »
Filed under: General Health News
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 [...]
No Comments »
Filed under: Pharmacy News
Amgen (NASDAQ: AMGN) announced the U.S. Food and Drug Administration (FDA) has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing [...]
No Comments »
Filed under: Pharmacy News
Science named the HIV Prevention Trials Network (HPTN) 052 study “Breakthrough of the Year.” FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a row that Science selected a trial for which FHI 360 provided scientific leadership and operational support…
No Comments »
Filed under: Pharmacy News
Denali Concrete Management Inc. (OTCBB: DCMG) announced that it has commenced patient enrollment for a phase 3 clinical study of the safety and efficacy of CF101, daily administered orally, in patients with moderate-to-severe Dry Eye Syndrome. This multi-center clinical trial is conducted in the United States, Europe and Israel…
No Comments »
Filed under: Pharmacy News
Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.
No Comments »
Filed under: Pharmacy News
HimalayaUSA announced today it is conducting a voluntary recall of Organique by Himalaya Nourishing Night Cream with batch #S691001 and batch #S691002 effective immediately.
No Comments »
Filed under: Pharmacy News
ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS Access program.
No Comments »
Filed under: Pharmacy News
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for treating patients with bucindolol based on genetic targeting and focused on a specific genotype - homozygous wildtype for Deletion 322-325 in the alpha-2C adrenergic receptor.
No Comments »
Filed under: Pharmacy News
Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the Company’s pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults.
No Comments »
Filed under: Pharmacy News
